Ryan Rhome is an Oncology physician affiliated with Advocate Illinois Masonic Medical Center. OpenAlex indexes 73 publications with 642 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
900 W Nelson St
Chicago, IL 606576704
Telephone
843-412-9919Provider last certified this registry record 9 Nov 2023.
Clinical trials
- A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy
Sponsor: Indiana University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teleflex LLCProgram year20252 payments
- Boston Scientific CorporationProgram year20241 payment
- Sumitomo Pharma America, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
44.2%alpha-Adrenergic Blocker44.2%Tamsulosin Hcl100%Part D<11 patientsMetabolism & gastrointestinal
34.6%Serotonin-3 Receptor Antagonist34.6%Ondansetron Hcl100%Part D<11 patientsNervous system
21.2%Opioid Agonist21.2%Tramadol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Analysis of Retrospective Versus Prospective Peer Review in a Multisite Academic Radiation Department
Advances in Radiation Oncology
2023 - Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): One-Year Safety and Efficacy Outcomes from a Multicenter Phase I Trial
International Journal of Radiation Oncology*Biology*Physics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Faris Murad, MD
Advocate Illinois Masonic Medical Center
Peter Stecy, MD
Advocate Illinois Masonic Medical Center
Monica Lai, MD
Advocate Illinois Masonic Medical Center
Terry Zheutlin, MD
Advocate Illinois Masonic Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”